AA
JNJ icon

Altman Advisors’s Johnson & Johnson JNJ Stock Holding History

Altman Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.37M Sell
9,713
-960
-9% -$224K 0.98% 33
2025
Q4 		$2.21M Sell
10,673
-37
-0.3% -$7.32K 0.83% 49
2025
Q3 		$1.99M Buy
10,710
+91
+0.9% +$15.6K 0.76% 57
2025
Q2 		$1.66M Buy
10,619
+268
+3% +$41.2K 0.68% 73
2025
Q1 		$1.62M Buy
10,351
+367
+4% +$57.4K 0.75% 70
2024
Q4 		$1.44M Buy
9,984
+273
+3% +$42.3K 0.62% 77
2024
Q3 		$1.57M Buy
+9,711
New +$1.55M 0.7% 76
2024
Q2 		– Sell
-9,335
Closed -$1.47M – 84
2024
Q1 		$1.47M Buy
9,335
+385
+4% +$61.3K 0.72% 69
2023
Q4 		$1.4M Buy
8,950
+140
+2% +$21.5K 0.74% 65
2023
Q3 		$1.37M Buy
+8,810
New +$1.45M 0.86% 51
2023
Q1 		$1.17M Buy
8,312
+289
+4% +$46.7K 1.07% 43
2022
Q4 		$1.4M Sell
8,023
-585
-7% -$101K 0.87% 42
2022
Q3 		$1.41M Buy
8,608
+139
+2% +$23.5K 0.89% 29
2022
Q2 		$1.46M Sell
8,469
-80
-0.9% -$14.3K 0.83% 34
2022
Q1 		$1.51M Sell
8,549
-8,936
-51% -$1.52M 0.78% 41
2021
Q4 		$2.88M Buy
17,485
+270
+2% +$44.2K 1.76% 21
2021
Q3 		$2.8M Buy
17,215
+73
+0.4% +$12.5K 1.55% 23
2021
Q2 		$2.98M Buy
17,142
+740
+5% +$123K 1.68% 16
2021
Q1 		$2.69M Sell
16,402
-990
-6% -$160K 1.74% 13
2020
Q4 		$2.74M Sell
17,392
-247
-1% -$36.5K 1.72% 15
2020
Q3 		$2.63M Buy
17,639
+310
+2% +$45.9K 1.86% 17
2020
Q2 		$2.44M Sell
17,329
-149
-0.9% -$21.7K 2.07% 13
2020
Q1 		$2.29M Sell
17,478
-743
-4% -$105K 2.13% 10
2019
Q4 		$2.66M Buy
18,221
+161
+0.9% +$21.8K 2.12% 16
2019
Q3 		$2.34M Buy
+18,060
New +$2.38M 1.98% 18
2018
Q3 		– Sell
-38,737
Closed -$1.51K – 80
2018
Q2 		$1.51K Buy
+38,737
New +$4.83M 1.39% 44

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Altman Advisors's JNJ Position: Q1 2026 in Review

Altman Advisors reduced its Johnson & Johnson (JNJ) stake by 9% in Q1 2026, selling an estimated $224K and leaving 9,713 shares worth $2.37M. The position accounts for 0.98% of the portfolio, ranked #33.

Altman Advisors first reported a position in JNJ in Q2 2018 and has held it in 26 quarters since. The position peaked at $2.98M in Q2 2021. 4,614 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Altman Advisors held 9,713 shares of Johnson & Johnson worth $2.37M as of Q1 2026.
  • Altman Advisors sold 960 Johnson & Johnson shares in Q1 2026, an estimated $224K.
  • Johnson & Johnson made up 0.98% of Altman Advisors's portfolio in Q1 2026, its #33 holding.
  • Altman Advisors first reported a position in Johnson & Johnson in Q2 2018 and has held it in 26 quarters since.
  • Altman Advisors's Johnson & Johnson position peaked at $2.98M in Q2 2021.
  • 4,614 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Altman Advisors's 13F filing for Q1 2026, filed 5 May 2026.